Hope Rugo is an Internal Medicine specialist and an Oncologist in San Francisco, California. Dr. Rugo is a global expert in HER-2 Positive Breast Cancer. She has been an author on 416 peer reviewed articles and participated in 966 clinical trials in the past 15 years. In particular, she has been an author on 43 peer reviewed articles regarding HER-2 Positive Breast Cancer. She is licensed to treat patients in CA.

Ian Krop is an Oncologist and an Internal Medicine specialist in Boston, Massachusetts. Dr. Krop is a global expert in HER-2 Positive Breast Cancer. He has been an author on 166 peer reviewed articles and participated in 144 clinical trials in the past 15 years. In particular, he has been an author on 40 peer reviewed articles and participated in 3 clinical trials regarding HER-2 Positive Breast Cancer. He is licensed to treat patients in MA.

John Crown is in Dublin, Ireland. Dr. Crown is a global expert in HER-2 Positive Breast Cancer. They have been an author on 195 peer reviewed articles and participated in 28 clinical trials in the past 15 years. In particular, they have been an author on 39 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Dr. Harbeck is a global expert in HER-2 Positive Breast Cancer. She has been an author on 449 peer reviewed articles and participated in 16 clinical trials in the past 15 years. In particular, she has been an author on 41 peer reviewed articles regarding HER-2 Positive Breast Cancer. Dr. Harbeck's top three areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Agranulocytosis.

Giuseppe Curigliano is in Milan, Italy. Dr. Curigliano is a global expert in HER-2 Positive Breast Cancer. He has been an author on 439 peer reviewed articles and participated in 6 clinical trials in the past 15 years. In particular, he has been an author on 44 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Sherene Loi is in Melbourne, Australia. Dr. Loi is a global expert in HER-2 Positive Breast Cancer. They have been an author on 234 peer reviewed articles and participated in 11 clinical trials in the past 15 years. In particular, they have been an author on 41 peer reviewed articles and participated in 1 clinical trial regarding HER-2 Positive Breast Cancer.

Sara Hurvitz is an Internal Medicine specialist and a Hematologist in Santa Monica, California. Dr. Hurvitz is a global expert in HER-2 Positive Breast Cancer. She has been an author on 131 peer reviewed articles and participated in 41 clinical trials in the past 15 years. In particular, she has been an author on 31 peer reviewed articles and participated in 4 clinical trials regarding HER-2 Positive Breast Cancer. Dr. Hurvitz's top three areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Metastatic Brain Tumor. She is licensed to treat patients in CA.

Eric Winer is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Winer is a global expert in HER-2 Positive Breast Cancer. He has been an author on 437 peer reviewed articles in the past 15 years. In particular, he has been an author on 62 peer reviewed articles regarding HER-2 Positive Breast Cancer. He is licensed to treat patients in MA.

Denise Yardley is a Hematologist and an Internal Medicine specialist in Tullahoma, Tennessee. Dr. Yardley is a global expert in HER-2 Positive Breast Cancer. She has been an author on 137 peer reviewed articles and participated in 22 clinical trials in the past 15 years. In particular, she has been an author on 30 peer reviewed articles and participated in 2 clinical trials regarding HER-2 Positive Breast Cancer. She is licensed to treat patients in TN.

Louise Hiller is in Coventry, United Kingdom. Dr. Hiller is a global expert in HER-2 Positive Breast Cancer. They have been an author on 50 peer reviewed articles in the past 15 years. In particular, they have been an author on 7 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Antonio Wolff is an Oncologist and an Internal Medicine specialist in Baltimore, Maryland. Dr. Wolff is a global expert in HER-2 Positive Breast Cancer. He has been an author on 249 peer reviewed articles and participated in 101 clinical trials in the past 15 years. In particular, he has been an author on 31 peer reviewed articles and participated in 1 clinical trial regarding HER-2 Positive Breast Cancer. Dr. Wolff's top three areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. He is licensed to treat patients in MD.

Aleix Prat is in Barcelona, Spain. Dr. Prat is a global expert in HER-2 Positive Breast Cancer. They have been an author on 152 peer reviewed articles and participated in 1 clinical trial in the past 15 years. In particular, they have been an author on 27 peer reviewed articles and participated in 1 clinical trial regarding HER-2 Positive Breast Cancer.

Adam Brufsky is an Oncologist in Pittsburgh, Pennsylvania. Dr. Brufsky is a global expert in HER-2 Positive Breast Cancer. He has been an author on 252 peer reviewed articles and participated in 65 clinical trials in the past 15 years. In particular, he has been an author on 34 peer reviewed articles and participated in 2 clinical trials regarding HER-2 Positive Breast Cancer. He is licensed to treat patients in PA.

Massimo Cristofanilli is an Internal Medicine specialist and an Oncologist in Chicago, Illinois. Dr. Cristofanilli is a global expert in HER-2 Positive Breast Cancer. He has been an author on 371 peer reviewed articles and participated in 78 clinical trials in the past 15 years. In particular, he has been an author on 42 peer reviewed articles regarding HER-2 Positive Breast Cancer. He is licensed to treat patients in IL.

Helena Earl is in Cambridge, United Kingdom. Dr. Earl is a global expert in HER-2 Positive Breast Cancer. They have been an author on 109 peer reviewed articles and participated in 39 clinical trials in the past 15 years. In particular, they have been an author on 8 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Anne Salomon-Vincent is in Paris, France. Dr. Salomon-Vincent is a global expert in HER-2 Positive Breast Cancer. They have been an author on 308 peer reviewed articles in the past 15 years. In particular, they have been an author on 31 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Kadri Altundag is in Cankaya, Turkey. Dr. Altundag is a global expert in HER-2 Positive Breast Cancer. They have been an author on 641 peer reviewed articles and participated in 1 clinical trial in the past 15 years. In particular, they have been an author on 68 peer reviewed articles regarding HER-2 Positive Breast Cancer.

Alessandra Fabi is in Rome, Italy. Dr. Fabi is a global expert in HER-2 Positive Breast Cancer. They have been an author on 208 peer reviewed articles and participated in 4 clinical trials in the past 15 years. In particular, they have been an author on 25 peer reviewed articles and participated in 1 clinical trial regarding HER-2 Positive Breast Cancer.

Sara Tolaney is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Tolaney is a global expert in HER-2 Positive Breast Cancer. She has been an author on 142 peer reviewed articles and participated in 428 clinical trials in the past 15 years. In particular, she has been an author on 21 peer reviewed articles and participated in 2 clinical trials regarding HER-2 Positive Breast Cancer. She is licensed to treat patients in MA.

Michael Untch is in Berlin, Germany. Dr. Untch is a global expert in HER-2 Positive Breast Cancer. They have been an author on 325 peer reviewed articles and participated in 4 clinical trials in the past 15 years. In particular, they have been an author on 43 peer reviewed articles regarding HER-2 Positive Breast Cancer.